Vicarious Surgical (NYSE:RBOT) Upgraded at Wall Street Zen

by · The Cerbat Gem

Wall Street Zen upgraded shares of Vicarious Surgical (NYSE:RBOT – Free Report) from a sell rating to a hold rating in a research report sent to investors on Saturday.

Several other research firms also recently commented on RBOT. BTIG Research restated a “neutral” rating on shares of Vicarious Surgical in a research note on Friday, December 12th. Weiss Ratings reissued a “sell (e+)” rating on shares of Vicarious Surgical in a report on Wednesday, October 8th. Two equities research analysts have rated the stock with a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Reduce” and an average price target of $7.00.

Read Our Latest Analysis on RBOT

Vicarious Surgical Trading Up 4.5%

NYSE:RBOT opened at $2.73 on Friday. The stock has a market cap of $17.87 million, a P/E ratio of -0.30 and a beta of 1.52. The stock has a 50 day simple moving average of $2.85 and a 200 day simple moving average of $5.66. Vicarious Surgical has a 1-year low of $1.80 and a 1-year high of $16.92.

Vicarious Surgical (NYSE:RBOT – Get Free Report) last issued its quarterly earnings data on Wednesday, November 12th. The company reported ($1.91) EPS for the quarter, beating analysts’ consensus estimates of ($2.37) by $0.46. As a group, sell-side analysts forecast that Vicarious Surgical will post -10.89 EPS for the current year.

Institutional Investors Weigh In On Vicarious Surgical

Several institutional investors and hedge funds have recently added to or reduced their stakes in RBOT. DNB Asset Management AS lifted its stake in shares of Vicarious Surgical by 12.1% in the 2nd quarter. DNB Asset Management AS now owns 29,199 shares of the company’s stock valued at $219,000 after acquiring an additional 3,154 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Vicarious Surgical by 22.1% during the 3rd quarter. Dimensional Fund Advisors LP now owns 19,975 shares of the company’s stock worth $110,000 after acquiring an additional 3,615 shares during the last quarter. Finally, Connective Capital Management LLC acquired a new position in Vicarious Surgical in the 3rd quarter worth about $169,000. 47.27% of the stock is currently owned by institutional investors.

Vicarious Surgical Company Profile

(Get Free Report)

Vicarious Surgical develops a next-generation robotic surgical system that integrates virtual reality (VR) with minimally invasive instrumentation. Its flagship offering combines ultra-slender, articulated robotic arms with a VR surgeon console, allowing physicians to perform laparoscopic procedures with enhanced precision, dexterity and visual immersion. The platform is designed to reduce patient trauma compared with traditional open or laparoscopic surgery and to expand surgeon access to challenging operative sites.

The company’s technology is intended for use across multiple surgical specialties, including general surgery, gynecology and urology.

Featured Articles